跳至主要内容
临床试验/ACTRN12608000186358
ACTRN12608000186358招募中3 期

Intravenous versus oral iron supplementation for correction of post-transplant anaemia in renal transplant patients

Princess Alexandra hospital (Department of nephrology)0 个研究点目标入组 100 人开始时间: 2008年4月10日最近更新:
适应症

试验速览

阶段
3 期
状态
招募中
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 o limit(—)
性别
All

入选标准

  • 1.New live or cadaveric donor renal transplant recipient
  • 2.Aged 18 years or over
  • 3.Able to give written informed consent.

排除标准

  • 1.Patients with transferrin saturation >50% or ferritin >800µg/l.
  • 2.Women lactating, pregnant or of child-bearing potential not using a reliable contraceptive method.
  • 3.Patients with a history of psychological illness or condition which interferes with their ability to understand or comply with the requirements of the study.
  • 4.Patients who have received a new investigational drug within the last 4 weeks.
  • 5.Intolerance of intravenous or oral iron supplements
  • 6.As the following medications can have interactive effects, they cannot be administered during the course of the study:
  • -All new investigational medications

研究者

发起方
Princess Alexandra hospital (Department of nephrology)

相似试验